Antidepressant effect of tetragonia tetragonoides (pall.) kuntzeextract on serotonin turnover
This 2019 study found that consuming tetragonia tetragonoides kuntze (TTK) extract can ameliorate the development of depressive-like symptoms in ovariectomized (OVX) rats. Tetragonia tetragonoides (pall.) kuntze (TTK) is a groundcover found along coastal areas of the Korean peninsula. It is used to improve women’s health and treat gastrointestinal diseases. To determine the mechanisms involved in the antidepressant-like effect of tetragonia tetragonoides kuntze (TTK) extract, this study analyzed the mRNA expression levels of tryptophan hydroxylases (TPH-1 and TPH-2) and serotonin transporter (SERT). In addition, the scientists monitored the reuptake activity of serotonin in RBL-2H3 cells. This study checked whether TTK extract can regulate the blood levels of serotonin and enhance depressive-like symptoms in OVX female rats fed 0.5, 1, and 2% TTK. The serum levels of serotonin of OVX female rats increased after the 1% and 2% TTK treatments. The forced swimming test showed reduced immobility times in the OVX female rats after the 1% and 2% TTK treatments. These results indicate that TTK may significantly inhibit depressive-like symptoms by increasing serotonin levels and regulating the serotonin reuptake activity. Individuals suffering from depression during pre- or/and postmenopausal periods (via modulation of serotonin synthesis and metabolism) may benefit from TTK. [NPID: tetragonia tetragonoides kuntze, TTK, depression, antidepressant, serotonin]
Year: 2019